institutionid,scoredate,scoretype,aspectname,scorevalue,gvkey,ticker,companyname
4092820,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,55,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Coverage of Environmental Management Policy,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Energy Use,90,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Reporting - Materiality,24,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Hazardous Waste,55,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),16,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Low-Carbon Products,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Water Use,82,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Analysis of Risks,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Audit Conflict of Interest,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Board Effectiveness,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Board Type,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Codes of Conduct: Coverage,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Corporate Governance Policy,88,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Critical Supplier Identification,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Customer Feedback Process,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Customer Satisfaction Measurement,27,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,ESG Integration in SCM Strategy,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Innovation,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Ethical Marketing - Complaints Tracking,15,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Open Innovation,85,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Process Innovations,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Product Innovations (Healthcare),19,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Core or Basic Research,26,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Development Stages,19,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Ideation or Applied Research,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Launch,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Post-Launch,30,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Spending,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Responsibility Risk & Crisis Management,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Risk Response Strategy,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sales Channels Variety & Innovation,51,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sales Effectiveness Targets,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sensitivity Analysis & Stress Testing,70,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Supplier Risk Management Measures,19,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Supply Chain Risk Exposure,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Supply Chain Transparency & Reporting,10,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Access to Genetic Resources,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Accessibility & Transparency of Outcome Data,6,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Benefits Sharing,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Bioethics Policy,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Business and Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,CEO Compensation - Success Metrics,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Corporate Citizenship Strategy,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Employee Support Programs,98,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Employee Turnover Rate,59,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Healthy Lifestyle Incentive,93,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Measure Contribution to Health Outcome,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Measuring Benefits,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Methods (biotech),100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Network Orientation,25,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Partnerships for Access to Healthcare,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Percentage of Performance Related Compensation for each E,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Personal and Organizational Learning and Development,70,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Philanthropic Contributions,53,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Coverage,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Materiality,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Quantitative Data,64,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Stakeholder Engagement Governance,15,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Stakeholder Engagement Implementation,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Stakeholder Engagement Review,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Trend of Employee Wellbeing,30,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Type of Performance Appraisal,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Volume,21,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Workforce Breakdown: Gender,18,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Dimension,Economic Governance Dimension,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Dimension,Environmental Dimension,73,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Dimension,Social Dimension,46,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Climate Strategy,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Environmental Policy & Management Systems,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Environmental Reporting,81,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Operational Eco-Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Business Ethics,65,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Corporate Governance,84,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Customer Relationship Management,67,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Innovation Management,41,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Marketing Practices,52,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Risk & Crisis Management,62,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Supply Chain Management,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Access to Healthcare,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Addressing Cost Burden,18,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Bioethics,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,47,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Health Outcome Contribution,10,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Human Capital Development,67,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Labor Practice Indicators,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Occupational Health & Safety,91,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Social Reporting,41,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Stakeholder Engagement,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Talent Attraction & Retention,69,001602,AMGN,Amgen Inc.
4092820,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,53,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Coverage of Environmental Management Policy,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Energy Use,90,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Reporting - Materiality,24,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Hazardous Waste,55,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),16,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Low-Carbon Products,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Water Use,82,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Analysis of Risks,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Audit Conflict of Interest,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Board Effectiveness,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Board Type,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Codes of Conduct: Coverage,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Corporate Governance Policy,88,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Critical Supplier Identification,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Customer Feedback Process,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Customer Satisfaction Measurement,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,ESG Integration in SCM Strategy,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Environmental Innovation,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Ethical Marketing - Complaints Tracking,15,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Open Innovation,85,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Process Innovations,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Core or Basic Research,26,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Development Stages,19,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Ideation or Applied Research,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Launch,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Post-Launch,30,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,R&D Spending,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Responsibility Risk & Crisis Management,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Risk Response Strategy,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sales Channels Variety & Innovation,51,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sales Effectiveness Targets,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Sensitivity Analysis & Stress Testing,70,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Supplier Risk Management Measures,19,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Supply Chain Risk Exposure,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Supply Chain Transparency & Reporting,10,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Access to Genetic Resources,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Accessibility & Transparency of Outcome Data,6,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Benefits Sharing,,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Bioethics Policy,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Business and Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,CEO Compensation - Success Metrics,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Corporate Citizenship Strategy,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Employee Support Programs,98,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Employee Turnover Rate,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Healthy Lifestyle Incentive,93,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,40,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Measure Contribution to Health Outcome,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Measuring Benefits,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Methods (biotech),100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Network Orientation,25,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Partnerships for Access to Healthcare,20,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Percentage of Performance Related Compensation for each E,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Personal and Organizational Learning and Development,70,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Philanthropic Contributions,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Coverage,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Materiality,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Social Reporting - Quantitative Data,64,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Stakeholder Engagement Governance,15,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Stakeholder Engagement Implementation,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Stakeholder Engagement Review,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Trend of Employee Wellbeing,30,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Type of Performance Appraisal,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Volume,0,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Question,Workforce Breakdown: Gender,18,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Dimension,Economic Governance Dimension,58,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Dimension,Environmental Dimension,73,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Dimension,Social Dimension,44,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Climate Strategy,60,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Environmental Policy & Management Systems,80,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Environmental Reporting,81,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Operational Eco-Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Business Ethics,65,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Corporate Governance,84,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Customer Relationship Management,62,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Innovation Management,37,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Marketing Practices,52,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Risk & Crisis Management,62,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Supply Chain Management,57,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Access to Healthcare,54,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Addressing Cost Burden,18,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Bioethics,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,26,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Health Outcome Contribution,10,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Human Capital Development,67,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Labor Practice Indicators,50,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Occupational Health & Safety,91,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Social Reporting,41,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Stakeholder Engagement,35,001602,AMGN,Amgen Inc.
4092820,2013-09-12,Criteria,Talent Attraction & Retention,66,001602,AMGN,Amgen Inc.
4092820,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,58,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate-Related Management Incentives,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Coverage of Environmental Management Policy,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),89,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Energy Use,79,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Reporting - Materiality,24,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Reporting - Quantitative Data,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Hazardous Waste,79,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),89,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Low-Carbon Products,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Waste Disposal,89,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Water Use,79,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Analysis of Risks,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Audit Conflict of Interest,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Diversity Policy,30,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Effectiveness,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Gender Diversity,22,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Type,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Codes of Conduct: Coverage,75,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Compliance to Regulatory Standards,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Corporate Governance Policy,88,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Critical Supplier Identification,78,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Customer Feedback Process,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Customer Satisfaction Measurement,17,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,ESG Integration in SCM Strategy,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Innovation,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Ethical Marketing - Complaints Tracking,85,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Expenses Associated with Product Recalls,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,24,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Open Innovation,85,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Process Innovations,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Product Innovations (Healthcare),12,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Product Recalls (Health Care),6,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Core or Basic Research,26,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Development Stages,19,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Ideation or Applied Research,28,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Launch,44,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Post-Launch,30,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Spending,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Responsibility Risk & Crisis Management,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Risk Response Strategy,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sales Channels Variety & Innovation,65,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sales Effectiveness Targets,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sensitivity Analysis & Stress Testing,70,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Supplier Risk Management Measures,24,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Supply Chain Risk Exposure,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Supply Chain Transparency & Reporting,10,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Tax Strategy and Governance,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Taxation Governance & Risks,25,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Access to Genetic Resources,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Accessibility & Transparency of Outcome Data,6,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,39,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Benefits Sharing,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Bioethics Policy,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Business and Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,CEO Compensation - Success Metrics,52,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Corporate Citizenship Strategy,90,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Employee Development Programs,49,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Employee Support Programs,98,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Fair Pricing,18,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Gender Pay Indicators,70,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,HTA Support of Value Proposition,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Healthy Lifestyle Incentive,93,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Labor KPIs - Layoffs,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,86,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Measure Contribution to Health Outcome,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Measuring Benefits,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Methods (biotech),100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Network Orientation,25,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Partnerships for Access to Healthcare,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Percentage of Performance Related Compensation for each E,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Philanthropic Contributions,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Public Commitment to Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Coverage,32,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Materiality,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Quantitative Data,10,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Stakeholder Engagement Governance,15,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Stakeholder Engagement Implementation,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Stakeholder Engagement Review,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Training & Development Inputs,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Trend of Employee Wellbeing,22,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Type of Performance Appraisal,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Type of Philanthropic Activities,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Volume,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Workforce Breakdown: Gender,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Dimension,Economic Governance Dimension,63,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Dimension,Environmental Dimension,71,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Dimension,Social Dimension,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Climate Strategy,57,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Environmental Policy & Management Systems,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Environmental Reporting,71,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Operational Eco-Efficiency,75,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Business Ethics,83,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Corporate Governance,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Customer Relationship Management,71,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Innovation Management,36,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Marketing Practices,81,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Product Quality & Recall Management,36,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Risk & Crisis Management,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Supply Chain Management,52,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Tax Strategy,55,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Access to Healthcare,72,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Addressing Cost Burden,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Bioethics,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Health Outcome Contribution,10,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Human Capital Development,42,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Labor Practice Indicators,68,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Occupational Health & Safety,72,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Social Reporting,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Stakeholder Engagement,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Talent Attraction & Retention,74,001602,AMGN,Amgen Inc.
4092820,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,54,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Climate-Related Management Incentives,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Coverage of Environmental Management Policy,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),89,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Energy Use,79,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Reporting - Materiality,24,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Reporting - Quantitative Data,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Hazardous Waste,79,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),89,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Low-Carbon Products,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Waste Disposal,89,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Water Use,79,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Analysis of Risks,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Audit Conflict of Interest,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Diversity Policy,30,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Effectiveness,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Gender Diversity,22,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Board Type,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Codes of Conduct: Coverage,75,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Compliance to Regulatory Standards,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Corporate Governance Policy,88,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Critical Supplier Identification,78,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Customer Feedback Process,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Customer Satisfaction Measurement,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,ESG Integration in SCM Strategy,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Environmental Innovation,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Ethical Marketing - Complaints Tracking,85,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Expenses Associated with Product Recalls,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Open Innovation,85,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Process Innovations,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Product Recalls (Health Care),0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Core or Basic Research,26,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Development Stages,19,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Ideation or Applied Research,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Launch,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Post-Launch,30,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,R&D Spending,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Responsibility Risk & Crisis Management,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Risk Response Strategy,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sales Channels Variety & Innovation,65,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sales Effectiveness Targets,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Sensitivity Analysis & Stress Testing,70,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Supplier Risk Management Measures,24,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Supply Chain Risk Exposure,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Supply Chain Transparency & Reporting,10,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Taxation Governance & Risks,25,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Access to Genetic Resources,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Accessibility & Transparency of Outcome Data,6,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Benefits Sharing,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Bioethics Policy,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Business and Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,CEO Compensation - Success Metrics,52,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Corporate Citizenship Strategy,90,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Employee Development Programs,49,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Employee Support Programs,98,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,HTA Support of Value Proposition,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Healthy Lifestyle Incentive,93,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Labor KPIs - Layoffs,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,86,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Measure Contribution to Health Outcome,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Measuring Benefits,50,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Methods (biotech),100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Network Orientation,25,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Partnerships for Access to Healthcare,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Percentage of Performance Related Compensation for each E,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Philanthropic Contributions,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Public Commitment to Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Coverage,32,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Materiality,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Social Reporting - Quantitative Data,10,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Stakeholder Engagement Governance,15,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Stakeholder Engagement Implementation,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Stakeholder Engagement Review,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Training & Development Inputs,100,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Trend of Employee Wellbeing,22,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Type of Performance Appraisal,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Volume,0,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Question,Workforce Breakdown: Gender,60,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Dimension,Economic Governance Dimension,59,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Dimension,Environmental Dimension,71,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Dimension,Social Dimension,44,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Climate Strategy,57,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Environmental Policy & Management Systems,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Environmental Reporting,71,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Operational Eco-Efficiency,75,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Business Ethics,83,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Corporate Governance,80,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Customer Relationship Management,68,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Innovation Management,27,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Marketing Practices,81,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Product Quality & Recall Management,20,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Risk & Crisis Management,62,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Supply Chain Management,49,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Tax Strategy,36,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Access to Healthcare,54,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Addressing Cost Burden,56,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Bioethics,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,28,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Health Outcome Contribution,10,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Human Capital Development,42,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Labor Practice Indicators,57,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Occupational Health & Safety,72,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Social Reporting,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Stakeholder Engagement,35,001602,AMGN,Amgen Inc.
4092820,2014-09-11,Criteria,Talent Attraction & Retention,69,001602,AMGN,Amgen Inc.
4092820,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,59,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Coverage of Environmental Management Policy,55,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Energy Use,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Environmental Reporting - Materiality,46,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Environmental Reporting - Quantitative Data,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Hazardous Waste,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Water Use,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Diversity Policy,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Effectiveness,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Type,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,CEO Compensation - Success Metrics,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Codes of Conduct: Coverage,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Compliance to Regulatory Standards,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Critical Supplier Identification,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Customer Satisfaction Measurement,28,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,ESG Integration in SCM Strategy,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Emerging Risks,11,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Ethical Marketing - Complaints Tracking,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Expenses Associated with Product Recalls,49,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Management Ownership Requirements,83,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Open Innovation,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Product Innovations (Healthcare),5,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Product Recalls (Health Care),0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Core or Basic Research,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Development Stages,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Ideation or Applied Research,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Launch,8,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Post-Launch,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Responsibilities and Committees,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Risk Governance,10,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Risks Correlation,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sales Channels Variety & Innovation,81,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sales Effectiveness Targets,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Supplier Risk Management Measures,22,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Supply Chain Risk Exposure,38,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Supply Chain Transparency & Reporting,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Taxation Governance & Risks,25,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Access to Genetic Resources,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Accessibility & Transparency of Outcome Data,82,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Benefits Sharing,45,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Bioethics Policy,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Business and Human Rights,28,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Corporate Citizenship Strategy,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Employee Development Programs,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Employee Support Programs,98,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Fair Pricing,26,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Gender Pay Indicators,33,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,HTA Support of Value Proposition,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Healthy Lifestyle Incentive,93,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Labor KPIs - Layoffs,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Measure Contribution to Health Outcome,8,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Measuring Benefits,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Methods (biotech),100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Network Orientation,25,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Partnerships for Access to Healthcare,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Philanthropic Contributions,29,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Public Commitment to Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Materiality,6,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Quantitative Data,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Stakeholder Engagement Governance,15,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Stakeholder Engagement Implementation,10,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Stakeholder Engagement Review,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Training & Development Inputs,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Trend of Employee Wellbeing,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Type of Performance Appraisal,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Volume,21,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Workforce Breakdown: Gender,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Dimension,Economic Governance Dimension,59,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Dimension,Environmental Dimension,77,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Dimension,Social Dimension,55,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Climate Strategy,71,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Environmental Policy & Management Systems,69,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Environmental Reporting,84,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Operational Eco-Efficiency,78,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Business Ethics,83,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Corporate Governance,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Customer Relationship Management,65,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Innovation Management,23,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Marketing Practices,84,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Product Quality & Recall Management,58,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Risk & Crisis Management,42,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Supply Chain Management,55,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Tax Strategy,36,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Access to Healthcare,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Addressing Cost Burden,56,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Bioethics,49,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Health Outcome Contribution,39,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Human Capital Development,43,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Labor Practice Indicators,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Occupational Health & Safety,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Social Reporting,64,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Stakeholder Engagement,37,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Talent Attraction & Retention,72,001602,AMGN,Amgen Inc.
4092820,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,57,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Coverage of Environmental Management Policy,55,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Energy Use,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Environmental Reporting - Materiality,46,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Environmental Reporting - Quantitative Data,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Hazardous Waste,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Water Use,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Diversity Policy,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Effectiveness,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Board Type,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,CEO Compensation - Success Metrics,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Codes of Conduct: Coverage,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Compliance to Regulatory Standards,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Critical Supplier Identification,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Customer Satisfaction Measurement,28,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,ESG Integration in SCM Strategy,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Emerging Risks,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Ethical Marketing - Complaints Tracking,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Expenses Associated with Product Recalls,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Management Ownership Requirements,83,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Open Innovation,70,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Product Recalls (Health Care),0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Core or Basic Research,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Development Stages,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Ideation or Applied Research,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Launch,8,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,R&D Post-Launch,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Responsibilities and Committees,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Risk Governance,10,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Risks Correlation,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sales Channels Variety & Innovation,81,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sales Effectiveness Targets,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Supplier Risk Management Measures,22,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Supply Chain Risk Exposure,38,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Supply Chain Transparency & Reporting,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Taxation Governance & Risks,25,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Access to Genetic Resources,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Accessibility & Transparency of Outcome Data,82,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Benefits Sharing,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Bioethics Policy,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Business and Human Rights,28,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Corporate Citizenship Strategy,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Employee Development Programs,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Employee Support Programs,98,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,HTA Support of Value Proposition,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Healthy Lifestyle Incentive,93,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Labor KPIs - Layoffs,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Measure Contribution to Health Outcome,8,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Measuring Benefits,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Methods (biotech),100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Network Orientation,25,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Partnerships for Access to Healthcare,20,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Philanthropic Contributions,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Public Commitment to Human Rights,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Materiality,6,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Social Reporting - Quantitative Data,50,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Stakeholder Engagement Governance,15,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Stakeholder Engagement Implementation,10,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Stakeholder Engagement Review,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Training & Development Inputs,100,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Trend of Employee Wellbeing,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Type of Performance Appraisal,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Volume,0,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Question,Workforce Breakdown: Gender,90,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Dimension,Economic Governance Dimension,58,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Dimension,Environmental Dimension,77,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Dimension,Social Dimension,52,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Climate Strategy,71,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Environmental Policy & Management Systems,69,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Environmental Reporting,84,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Operational Eco-Efficiency,78,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Business Ethics,83,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Corporate Governance,75,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Customer Relationship Management,65,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Innovation Management,22,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Marketing Practices,84,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Product Quality & Recall Management,48,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Risk & Crisis Management,41,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Supply Chain Management,55,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Tax Strategy,36,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Access to Healthcare,54,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Addressing Cost Burden,47,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Bioethics,35,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,28,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Health Outcome Contribution,39,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Human Capital Development,43,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Labor Practice Indicators,65,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Occupational Health & Safety,80,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Social Reporting,64,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Stakeholder Engagement,37,001602,AMGN,Amgen Inc.
4092820,2015-09-10,Criteria,Talent Attraction & Retention,72,001602,AMGN,Amgen Inc.
4092820,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,55,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Coverage of Environmental Management Policy,55,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Energy Use,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Hazardous Waste,46,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Water Use,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Diversity Policy,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Effectiveness,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Type,90,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,CEO Compensation - Success Metrics,63,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Codes of Conduct: Coverage,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Compliance to Regulatory Standards,30,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Critical Supplier Identification,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,ESG Integration in SCM Strategy,69,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Emerging Risks,17,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Ethical Marketing - Complaints Tracking,31,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Expenses Associated with Product Recalls,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Management Ownership Requirements,83,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Material Issues for Enterprise Value Creation,69,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Materiality Analysis,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Open Innovation,42,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Product Innovations (Healthcare),9,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Product Recalls (Health Care),86,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Core or Basic Research,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Development Stages,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Ideation or Applied Research,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Launch,8,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Post-Launch,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Risk Governance,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Risks Correlation,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,40,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Supplier Risk Management Measures,32,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Supply Chain Risk Exposure,38,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Supply Chain Transparency & Reporting,26,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Taxation Governance & Risks,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Access to Medicine Strategy Reporting,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Accessibility & Transparency of Outcome Data,82,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,40,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Corporate Citizenship Strategy,68,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Employee Support Programs,86,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Fair Pricing,74,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Gender Pay Indicators,38,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Governance,25,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Healthy Lifestyle Incentive,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Assessment,85,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Commitment,67,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Due Diligence Process,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Mitigation & Remediation,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Labor KPIs - Layoffs,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Local Capacity Building,23,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Measure Contribution to Health Outcome,8,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Network Orientation,30,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Philanthropic Contributions,21,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Social Reporting - Coverage,89,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Social Reporting - Quantitative Data,43,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Training & Development Inputs,25,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Trend of Employee Wellbeing,10,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Type of Performance Appraisal,36,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Workforce Breakdown: Gender,90,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Dimension,Economic Governance Dimension,57,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Dimension,Environmental Dimension,74,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Dimension,Social Dimension,49,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Climate Strategy,71,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Environmental Policy & Management Systems,69,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Operational Eco-Efficiency,61,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Business Ethics,85,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Corporate Governance,77,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Innovation Management,10,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Marketing Practices,67,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Materiality,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Product Quality & Recall Management,63,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Risk & Crisis Management,43,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Supply Chain Management,63,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Tax Strategy,30,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Access to Healthcare,12,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Addressing Cost Burden,64,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,35,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Health Outcome Contribution,41,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Human Capital Development,33,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Labor Practice Indicators,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Occupational Health & Safety,76,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Social Reporting,78,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Talent Attraction & Retention,65,001602,AMGN,Amgen Inc.
4092820,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,53,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate Change Governance,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate Strategy Impacts,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Coverage of Environmental Management Policy,55,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Energy Use,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Hazardous Waste,46,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Water Use,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Diversity Policy,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Effectiveness,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Board Type,90,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,CEO Compensation - Success Metrics,63,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Codes of Conduct: Coverage,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Compliance to Regulatory Standards,30,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Critical Supplier Identification,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,ESG Integration in SCM Strategy,69,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Emerging Risks,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Expenses Associated with Product Recalls,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Management Ownership Requirements,83,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Material Issues for Enterprise Value Creation,69,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Materiality Analysis,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Open Innovation,42,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Opportunities,60,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Product Recalls (Health Care),86,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Core or Basic Research,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Development Stages,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Ideation or Applied Research,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Launch,8,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,R&D Post-Launch,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Risk Governance,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Risks Correlation,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,40,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Service Orientation,35,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Supplier Risk Management Measures,32,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Supply Chain Risk Exposure,38,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Supply Chain Transparency & Reporting,26,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Taxation Governance & Risks,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Transparency of Executive Compensation,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Access to Medicine Strategy Reporting,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Accessibility & Transparency of Outcome Data,82,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,40,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Corporate Citizenship Strategy,68,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Employee Support Programs,86,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Fair Pricing,74,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Governance,25,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Health Management,75,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Healthy Lifestyle Incentive,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Capital Performance Indicators,40,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Assessment,85,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Commitment,67,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Due Diligence Process,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Human Rights Mitigation & Remediation,20,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Labor KPIs - Layoffs,50,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Local Capacity Building,23,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Measure Contribution to Health Outcome,8,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Network Orientation,30,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Philanthropic Contributions,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Social Reporting - Coverage,89,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Social Reporting - Quantitative Data,43,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Training & Development Inputs,25,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Trend of Employee Wellbeing,10,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Type of Performance Appraisal,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Type of Philanthropic Activities,0,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Question,Workforce Breakdown: Gender,90,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Dimension,Economic Governance Dimension,56,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Dimension,Environmental Dimension,74,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Dimension,Social Dimension,47,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Climate Strategy,71,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Environmental Policy & Management Systems,69,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Operational Eco-Efficiency,61,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Business Ethics,85,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Corporate Governance,77,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Innovation Management,8,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Marketing Practices,59,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Materiality,70,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Product Quality & Recall Management,63,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Risk & Crisis Management,43,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Supply Chain Management,63,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Tax Strategy,30,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Access to Healthcare,12,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Addressing Cost Burden,64,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,27,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Health Outcome Contribution,41,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Human Capital Development,33,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Labor Practice Indicators,55,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Occupational Health & Safety,76,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Social Reporting,78,001602,AMGN,Amgen Inc.
4092820,2016-09-08,Criteria,Talent Attraction & Retention,58,001602,AMGN,Amgen Inc.
4092820,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Climate Strategy - CDP Alignment,,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Coverage of Environmental Management Policy,44,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Energy Consumption,70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Hazardous Waste,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Waste Disposal,57,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Water Consumption,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Anti-Competitive Practices,31,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Average Tenure,85,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Effectiveness,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Industry Experience,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Type,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,CEO Compensation - Success Metrics,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Compliance to Regulatory Standards,68,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Contributions & Other Spending,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Corruption & Bribery Cases,61,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,ESG Integration in SCM Strategy,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Emerging Risks,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Ethical Marketing - Complaints Tracking,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Expenses Associated with Product Recalls,47,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Impact Valuation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Management Ownership Requirements,83,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Material Issues for Enterprise Value Creation,85,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Materiality Analysis,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Open Innovation,75,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Product Innovations (Healthcare),11,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Core or Basic Research,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Development Stages,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Ideation or Applied Research,22,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Launch,38,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Risk Culture,48,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Risk Governance,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Risks Correlation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,25,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supply Chain Transparency & Reporting,30,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Taxation Governance & Risks,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Valuation Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Access to Medicine Strategy Reporting,54,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Corporate Citizenship Strategy,83,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Employee Development Programs,55,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Employee Support Programs,76,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Employee Turnover Rate,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Fair Pricing,92,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Gender Pay Indicators,90,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Governance,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Healthy Lifestyle Incentive,88,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Capital Return on Investment,79,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Assessment,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Commitment,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Due Diligence Process,90,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Local Capacity Building,30,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Measure Contribution to Health Outcome,55,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Network Orientation,85,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Philanthropic Contributions,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Social Reporting - Coverage,89,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Social Reporting - Quantitative Data,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Training & Development Inputs,32,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Trend of Employee Wellbeing,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Type of Performance Appraisal,40,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Workforce Breakdown: Gender,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Dimension,Economic Governance Dimension,61,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Dimension,Environmental Dimension,69,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Dimension,Social Dimension,64,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Climate Strategy,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Environmental Policy & Management Systems,66,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Operational Eco-Efficiency,55,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Business Ethics,78,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Corporate Governance,65,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Impact Measurement & Valuation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Innovation Management,22,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Marketing Practices,74,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Materiality,78,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Policy Influence,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Product Quality & Recall Management,81,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Risk & Crisis Management,43,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Supply Chain Management,71,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Tax Strategy,30,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Access to Healthcare,35,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Addressing Cost Burden,79,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,91,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Health Outcome Contribution,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Human Capital Development,40,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Human Rights,44,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Labor Practice Indicators,65,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Occupational Health & Safety,64,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Social Reporting,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Talent Attraction & Retention,70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,58,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Climate Strategy - CDP Alignment,,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Coverage of Environmental Management Policy,44,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,EP - Biological Oxygen Demand,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Energy Consumption,70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Hazardous Waste,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),32,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Waste Disposal,57,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Water Consumption,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Anti-Competitive Practices,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Average Tenure,85,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Effectiveness,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Gender Diversity,18,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Industry Experience,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Board Type,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,CEO Compensation - Success Metrics,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Compliance to Regulatory Standards,68,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Contributions & Other Spending,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Corruption & Bribery Cases,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,ESG Integration in SCM Strategy,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Emerging Risks,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Expenses Associated with Product Recalls,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Impact Valuation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Management Ownership Requirements,83,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Material Issues for Enterprise Value Creation,85,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Materiality Analysis,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Open Innovation,75,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Core or Basic Research,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Development Stages,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Ideation or Applied Research,22,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Launch,38,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Responsibilities and Committees,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Risk Culture,48,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Risk Governance,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Risks Correlation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,25,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Supply Chain Transparency & Reporting,30,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Taxation Governance & Risks,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Valuation Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Access to Medicine Strategy Reporting,54,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Corporate Citizenship Strategy,83,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Employee Development Programs,55,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Employee Support Programs,76,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Employee Turnover Rate,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Fair Pricing,92,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Governance,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Healthy Lifestyle Incentive,88,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Assessment,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Commitment,20,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Local Capacity Building,30,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Measure Contribution to Health Outcome,55,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Network Orientation,85,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Philanthropic Contributions,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Social Reporting - Coverage,89,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Social Reporting - Quantitative Data,50,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Trend of Employee Wellbeing,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Type of Performance Appraisal,40,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Question,Workforce Breakdown: Gender,10,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Dimension,Economic Governance Dimension,56,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Dimension,Environmental Dimension,69,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Dimension,Social Dimension,58,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Climate Strategy,63,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Environmental Policy & Management Systems,66,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Operational Eco-Efficiency,55,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Business Ethics,69,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Corporate Governance,65,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Impact Measurement & Valuation,0,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Innovation Management,19,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Marketing Practices,59,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Materiality,78,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Policy Influence,100,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Product Quality & Recall Management,71,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Risk & Crisis Management,43,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Supply Chain Management,71,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Tax Strategy,30,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Access to Healthcare,35,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Addressing Cost Burden,79,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,91,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Health Outcome Contribution,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Human Capital Development,17,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Human Rights,26,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Labor Practice Indicators,43,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Occupational Health & Safety,64,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Social Reporting,80,001602,AMGN,Amgen Inc.
4092820,2017-09-07,Criteria,Talent Attraction & Retention,70,001602,AMGN,Amgen Inc.
4092820,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Climate Strategy - CDP Alignment,,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Coverage of Environmental Management Policy,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,EP - Biological Oxygen Demand,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Emissions Reduction Targets,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Energy Consumption,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Hazardous Waste,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Waste Disposal,71,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Water Consumption,95,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Anti-Competitive Practices,34,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Average Tenure,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Gender Diversity,44,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Industry Experience,42,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Type,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,CEO Compensation - Success Metrics,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Compliance to Regulatory Standards,71,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Contributions & Other Spending,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Corruption & Bribery Cases,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,ESG Integration in SCM Strategy,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Emerging Risks,35,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Ethical Marketing - Complaints Tracking,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Family Ownership,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Materiality Analysis,75,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Open Innovation,90,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Product Innovations (Healthcare),13,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Core or Basic Research,22,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Development Stages,10,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Ideation or Applied Research,34,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Launch,38,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Risk Culture,48,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Risk Governance,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,25,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supply Chain Transparency & Reporting,30,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Access to Medicine Strategy Reporting,36,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Corporate Citizenship Strategy,93,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Employee Support Programs,73,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Employee Turnover Rate,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Fair Pricing,92,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Gender Pay Indicators,65,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Capital Return on Investment,79,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Assessment,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Commitment,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Due Diligence Process,65,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Local Capacity Building,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,92,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Measure Contribution to Health Outcome,45,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Patent Filing Policy,83,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Philanthropic Contributions,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Social Reporting - Quantitative Data,54,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Training & Development Inputs,55,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Trend of Employee Wellbeing,23,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Type of Performance Appraisal,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Workforce Breakdown: Gender,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Dimension,Economic Governance Dimension,57,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Dimension,Environmental Dimension,68,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Dimension,Social Dimension,65,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Climate Strategy,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Environmental Policy & Management Systems,55,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Operational Eco-Efficiency,59,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Business Ethics,76,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Corporate Governance,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Innovation Management,27,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Marketing Practices,53,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Materiality,69,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Policy Influence,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Product Quality & Recall Management,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Risk & Crisis Management,37,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Supply Chain Management,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Access to Healthcare,72,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Addressing Cost Burden,70,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,96,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Health Outcome Contribution,73,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Human Capital Development,51,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Human Rights,31,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Labor Practice Indicators,45,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Occupational Health & Safety,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Social Reporting,85,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Talent Attraction & Retention,66,001602,AMGN,Amgen Inc.
4092820,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,57,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Climate Strategy - CDP Alignment,,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Coverage of Environmental Management Policy,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,EP - Biological Oxygen Demand,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Emissions Reduction Targets,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Energy Consumption,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Hazardous Waste,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Waste Disposal,71,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Water Consumption,95,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Anti-Competitive Practices,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Average Tenure,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Gender Diversity,44,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Industry Experience,42,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Board Type,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,CEO Compensation - Success Metrics,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Compliance to Regulatory Standards,71,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Contributions & Other Spending,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Corruption & Bribery Cases,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,ESG Integration in SCM Strategy,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Emerging Risks,35,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Ethical Marketing - Complaints Tracking,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Family Ownership,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Materiality Analysis,75,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Open Innovation,90,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Core or Basic Research,22,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Development Stages,10,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Ideation or Applied Research,34,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Launch,38,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Risk Culture,48,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Risk Governance,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,25,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Supply Chain Transparency & Reporting,30,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Access to Medicine Strategy Reporting,36,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Corporate Citizenship Strategy,93,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Employee Support Programs,73,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Employee Turnover Rate,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Fair Pricing,92,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Assessment,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Commitment,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Local Capacity Building,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,10,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,92,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Measure Contribution to Health Outcome,45,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Philanthropic Contributions,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Social Reporting - Quantitative Data,54,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Trend of Employee Wellbeing,23,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Type of Performance Appraisal,40,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Question,Workforce Breakdown: Gender,20,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Dimension,Economic Governance Dimension,55,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Dimension,Environmental Dimension,68,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Dimension,Social Dimension,56,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Climate Strategy,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Environmental Policy & Management Systems,55,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Operational Eco-Efficiency,59,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Business Ethics,64,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Corporate Governance,60,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Innovation Management,24,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Marketing Practices,53,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Materiality,69,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Policy Influence,100,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Product Quality & Recall Management,80,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Risk & Crisis Management,37,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Supply Chain Management,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Access to Healthcare,50,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Addressing Cost Burden,70,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,96,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Health Outcome Contribution,73,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Human Capital Development,21,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Human Rights,15,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Labor Practice Indicators,21,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Occupational Health & Safety,61,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Social Reporting,85,001602,AMGN,Amgen Inc.
4092820,2018-09-13,Criteria,Talent Attraction & Retention,66,001602,AMGN,Amgen Inc.
4092820,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,63,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Coverage of Environmental Management Policy,80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Emissions Reduction Targets,80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Energy Consumption,80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Hazardous Waste,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Waste Disposal,82,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Water Consumption,90,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Anti-Competitive Practices,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Average Tenure,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,CEO Compensation - Success Metrics,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Compliance to Regulatory Standards,84,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Contributions & Other Spending,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Corruption & Bribery Cases,56,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,ESG Integration in SCM Strategy,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Emerging Risks,35,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Ethical Marketing - Complaints Tracking,64,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Materiality Analysis,75,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Open Innovation,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Product Innovations (Healthcare),7,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Core or Basic Research,12,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Development Stages,10,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Ideation or Applied Research,34,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Launch,38,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Risk Culture,48,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Risk Governance,40,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,25,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supplier Risk Management Measures,33,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supply Chain Transparency & Reporting,30,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Access to Medicine Strategy Reporting,36,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Corporate Citizenship Strategy,93,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Employee Support Programs,10,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Employee Turnover Rate,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Fair Pricing,92,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Gender Pay Indicators,64,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,HTA Support of Value Proposition,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Capital Return on Investment,52,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Assessment,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Commitment,40,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Due Diligence Process,51,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Local Capacity Building,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Measure Contribution to Health Outcome,96,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Patent Filing Policy,91,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Philanthropic Contributions,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Social Reporting - Quantitative Data,54,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Training & Development Inputs,74,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Trend of Employee Wellbeing,9,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Type of Performance Appraisal,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Workforce Breakdown: Gender,78,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Dimension,Economic Governance Dimension,58,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Dimension,Environmental Dimension,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Dimension,Social Dimension,68,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Climate Strategy,61,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Environmental Policy & Management Systems,64,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Operational Eco-Efficiency,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Business Ethics,69,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Corporate Governance,66,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Innovation Management,25,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Marketing Practices,52,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Materiality,69,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Policy Influence,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Product Quality & Recall Management,86,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Risk & Crisis Management,37,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Supply Chain Management,62,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Access to Healthcare,74,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Addressing Cost Burden,71,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,96,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Health Outcome Contribution,98,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Human Capital Development,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Human Rights,28,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Labor Practice Indicators,65,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Occupational Health & Safety,48,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Social Reporting,85,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Talent Attraction & Retention,67,001602,AMGN,Amgen Inc.
4092820,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,57,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Coverage of Environmental Management Policy,80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Emissions Reduction Targets,80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Energy Consumption,80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Financial Risks of Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Hazardous Waste,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Waste Disposal,82,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Water Consumption,90,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Anti-Competitive Practices,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Average Tenure,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,CEO Compensation - Success Metrics,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Compliance to Regulatory Standards,84,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Contributions & Other Spending,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Corruption & Bribery Cases,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,ESG Integration in SCM Strategy,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Emerging Risks,35,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Materiality Analysis,75,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Open Innovation,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Process Innovations,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Core or Basic Research,12,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Development Stages,10,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Ideation or Applied Research,34,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Launch,38,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Risk Culture,48,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Risk Governance,40,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,25,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supplier Risk Management Measures,33,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Supply Chain Transparency & Reporting,30,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Access to Medicine Strategy Reporting,36,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Corporate Citizenship Strategy,93,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Employee Support Programs,10,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Employee Turnover Rate,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Fair Pricing,92,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Fatalities,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,HTA Support of Value Proposition,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Assessment,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Commitment,40,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Local Capacity Building,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Long-Term Incentives for Employees,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,20,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Measure Contribution to Health Outcome,96,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Philanthropic Contributions,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Social Reporting - Quantitative Data,54,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Trend of Employee Wellbeing,9,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Type of Performance Appraisal,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Question,Workforce Breakdown: Gender,78,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Dimension,Economic Governance Dimension,53,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Dimension,Environmental Dimension,70,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Dimension,Social Dimension,59,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Climate Strategy,61,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Environmental Policy & Management Systems,64,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Operational Eco-Efficiency,60,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Business Ethics,56,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Corporate Governance,66,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Innovation Management,23,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Marketing Practices,29,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Materiality,69,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Policy Influence,100,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Product Quality & Recall Management,86,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Risk & Crisis Management,37,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Supply Chain Management,62,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Access to Healthcare,50,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Addressing Cost Burden,71,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,96,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Health Outcome Contribution,98,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Human Capital Development,21,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Human Rights,15,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Labor Practice Indicators,42,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Occupational Health & Safety,48,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Social Reporting,85,001602,AMGN,Amgen Inc.
4092820,2019-09-13,Criteria,Talent Attraction & Retention,67,001602,AMGN,Amgen Inc.
4092820,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,66,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),39,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Emissions Reduction Targets,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Energy Consumption,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Hazardous Waste,30,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Waste Disposal,44,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Water Consumption,72,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Average Tenure,71,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,CEO Compensation - Success Metrics,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Compliance to Regulatory Standards,85,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Contributions & Other Spending,83,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Corruption & Bribery Cases,81,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,ESG Integration in SCM Strategy,70,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Ethical Marketing - Complaints Tracking,91,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,IT Security/ Cybersecurity Governance,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,IT Security/ Cybersecurity Measures,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Open Innovation,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Process Innovations,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Product Innovations (Healthcare),9,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,R&D breakout by Innovation Phase,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Risk Culture,16,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Risk Governance,20,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,75,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supplier Risk Management Measures,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supply Chain Transparency & Reporting,36,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Access to Medicine Strategy Reporting,54,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Corporate Citizenship Strategy,97,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Employee Support Programs,28,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Fair Pricing,67,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Fatalities,75,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Gender Pay Indicators,81,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Capital Return on Investment,51,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Assessment,30,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Commitment,40,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Due Diligence Process,38,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Patent Filing Policy,54,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Philanthropic Contributions,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Training & Development Inputs,65,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Type of Performance Appraisal,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Workforce Breakdown: Gender,79,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Dimension,Economic Governance Dimension,65,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Dimension,Environmental Dimension,65,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Dimension,Social Dimension,67,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Climate Strategy,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Environmental Policy & Management Systems,45,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Operational Eco-Efficiency,59,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Business Ethics,74,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Corporate Governance,66,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,40,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Innovation Management,61,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Marketing Practices,69,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Materiality,62,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Policy Influence,89,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Product Quality & Recall Management,87,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Risk & Crisis Management,38,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Supply Chain Management,76,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Access to Healthcare,67,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Addressing Cost Burden,71,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,94,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Human Capital Development,47,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Human Rights,27,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Labor Practice Indicators,72,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Occupational Health & Safety,54,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Talent Attraction & Retention,55,001602,AMGN,Amgen Inc.
4092820,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,59,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),39,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,EMS: Certification/ Audit/ Verification,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Emissions Reduction Targets,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Energy Consumption,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Financial Opportunities Arising from Climate Change,20,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Hazardous Waste,30,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Waste Disposal,44,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Water Consumption,72,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Average Tenure,71,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,CEO Compensation - Success Metrics,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Compliance to Regulatory Standards,85,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Contributions & Other Spending,83,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Corruption & Bribery Cases,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Critical Supplier Identification,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,ESG Integration in SCM Strategy,70,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,IT Security/ Cybersecurity Governance,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,IT Security/ Cybersecurity Measures,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Open Innovation,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Process Innovations,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Product Innovations (Healthcare),0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Product Recalls (Health Care),89,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,R&D breakout by Innovation Phase,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Risk Culture,16,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Risk Governance,20,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,75,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supplier Risk Management Measures,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Supply Chain Transparency & Reporting,36,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Access to Medicine Strategy Reporting,54,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Corporate Citizenship Strategy,97,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Employee Support Programs,28,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Fatalities,75,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Freedom of Association,50,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Assessment,30,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Commitment,40,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Philanthropic Contributions,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Return on Employee Development Investment,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Type of Performance Appraisal,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Question,Workforce Breakdown: Gender,79,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Dimension,Economic Governance Dimension,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Dimension,Environmental Dimension,65,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Dimension,Social Dimension,57,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Climate Strategy,60,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Environmental Policy & Management Systems,45,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Operational Eco-Efficiency,59,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Business Ethics,63,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Corporate Governance,66,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,40,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Innovation Management,58,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Marketing Practices,33,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Materiality,62,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Policy Influence,89,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Product Quality & Recall Management,87,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Risk & Crisis Management,38,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Supply Chain Management,76,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Access to Healthcare,53,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Addressing Cost Burden,47,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,94,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Human Capital Development,21,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Human Rights,18,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Labor Practice Indicators,43,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Occupational Health & Safety,54,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2020-11-13,Criteria,Talent Attraction & Retention,55,001602,AMGN,Amgen Inc.
4092820,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,67,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate Risk Assessment - Transition Risks,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate-Related Scenario Analysis,30,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,EMS: Certification/ Audit/ Verification,51,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Energy Consumption,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Hazardous Waste,77,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Physical Climate Risk Adaptation,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Waste Disposal,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Water Consumption,68,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Average Tenure,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Gender Diversity,58,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Industry Experience,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Type,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Compliance to Regulatory Standards,87,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Contributions & Other Spending,83,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Corruption & Bribery Cases,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Critical Supplier Identification,83,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,ESG Integration in SCM Strategy,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Effective Tax Rate,33,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Ethical Marketing - Complaints Tracking,92,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,IT Security/ Cybersecurity Governance,38,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,IT Security/ Cybersecurity Measures,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Open Innovation,95,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Process Innovations,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Product Recalls (Health Care),70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,R&D breakout by Innovation Phase,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Risk Governance,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supply Chain Transparency & Reporting,38,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Access to Medicine Strategy Reporting,54,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Corporate Citizenship Strategy,85,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Discrimination & Harassment,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Employee Support Programs,10,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Fair Pricing,67,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Gender Pay Indicators,46,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Hiring,69,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Capital Return on Investment,51,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Assessment,34,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Commitment,54,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Patent Filing Policy,28,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,People Analytics,92,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Philanthropic Contributions,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Strategic Workforce Planning,81,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Training & Development Inputs,58,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Type of Performance Appraisal,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Workforce Breakdown: Gender,79,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Workforce Breakdown: Other Minorities,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Dimension,Economic Governance Dimension,64,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Dimension,Environmental Dimension,73,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Dimension,Social Dimension,69,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Climate Strategy,55,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Environmental Policy & Management Systems,46,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Operational Eco-Efficiency,85,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Business Ethics,77,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Corporate Governance,66,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,35,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Innovation Management,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Marketing Practices,70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Materiality,62,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Policy Influence,89,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Product Quality & Recall Management,79,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Risk & Crisis Management,44,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Supply Chain Management,71,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Tax Strategy,7,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Access to Healthcare,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Addressing Cost Burden,71,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,88,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Human Capital Development,61,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Human Rights,22,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Labor Practice Indicators,46,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Occupational Health & Safety,67,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Talent Attraction & Retention,72,001602,AMGN,Amgen Inc.
4092820,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate Risk Assessment - Transition Risks,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Climate-Related Scenario Analysis,30,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,EMS: Certification/ Audit/ Verification,51,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Energy Consumption,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Hazardous Waste,77,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Physical Climate Risk Adaptation,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Waste Disposal,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Water Consumption,68,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Average Tenure,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Gender Diversity,58,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Industry Experience,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Board Type,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Codes of Conduct: Coverage,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Compliance to Regulatory Standards,87,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Contributions & Other Spending,83,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Corruption & Bribery Cases,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Critical Supplier Identification,83,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,ESG Integration in SCM Strategy,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Effective Tax Rate,33,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,IT Security/ Cybersecurity Governance,38,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,IT Security/ Cybersecurity Measures,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Open Innovation,95,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Process Innovations,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Product Recalls (Health Care),70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,R&D breakout by Innovation Phase,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Reporting on breaches,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Risk Governance,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supply Chain Risk Exposure,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Supply Chain Transparency & Reporting,38,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Access to Medicine Strategy Reporting,54,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Corporate Citizenship Strategy,85,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Discrimination & Harassment,50,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Employee Development Programs,70,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Employee Support Programs,10,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Employee Turnover Rate,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Hiring,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Assessment,34,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Commitment,54,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,People Analytics,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Philanthropic Contributions,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Strategic Workforce Planning,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Type of Performance Appraisal,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Workforce Breakdown: Gender,79,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Workforce Breakdown: Other Minorities,0,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Dimension,Economic Governance Dimension,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Dimension,Environmental Dimension,73,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Dimension,Social Dimension,58,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Climate Strategy,55,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Environmental Policy & Management Systems,46,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Operational Eco-Efficiency,85,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Business Ethics,77,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Corporate Governance,66,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,35,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Innovation Management,60,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Marketing Practices,33,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Materiality,62,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Policy Influence,89,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Product Quality & Recall Management,79,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Risk & Crisis Management,44,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Supply Chain Management,71,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Tax Strategy,7,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Access to Healthcare,53,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Addressing Cost Burden,47,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,88,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Human Capital Development,28,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Human Rights,22,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Labor Practice Indicators,37,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Occupational Health & Safety,67,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2021-11-12,Criteria,Talent Attraction & Retention,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,S&P Global ESG Score,S&P Global ESG Score,62,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Biodiversity Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate Risk Assessment - Transition Risks,28,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate-Related Scenario Analysis,30,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,EMS: Certification/ Audit/ Verification,51,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Energy Consumption,72,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Environmental Policy & Commitments,37,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Hazardous Waste,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Net-Zero Commitment,8,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,No Deforestation Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Physical Climate Risk Adaptation,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Water Consumption,67,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Average Tenure,98,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Codes of Conduct: Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Compliance to Regulatory Standards,55,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Contributions & Other Spending,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Corruption & Bribery Cases,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Critical Supplier Identification,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,ESG Integration in SCM Strategy,90,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Effective Tax Rate,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,IT Security/ Cybersecurity Governance,25,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,IT Security/ Cybersecurity Measures,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,IT Security/ Cybersecurity Process & Infrastructure,23,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Material Issues for Enterprise Value Creation,58,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Open Innovation,95,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Process Innovations,54,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Product Recalls (Health Care),71,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,R&D breakout by Innovation Phase,40,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Reporting on breaches,17,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Risk Governance,10,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supply Chain Risk Exposure,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supply Chain Transparency & Reporting,36,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,UN Global Compact Membership,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Access to Healthcare Programs (Products & Drugs),40,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Corporate Citizenship Strategy,68,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Discrimination & Harassment,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Employee Development Programs,76,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Employee Support Programs,64,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Employee Turnover Rate,63,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Ethical Marketing - Complaints Tracking,89,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Fair Pricing,67,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Gender Pay Indicators,30,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Hiring,42,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Capital Return on Investment,45,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Assessment,34,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Commitment,84,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Impact on Access to Healthcare,71,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Long-Term Incentives for Employees,81,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,OHS Policy,66,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,OHS Programs,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Patent Filing Policy,71,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,People Analytics,89,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Philanthropic Contributions,26,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Strategic Workforce Planning,77,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Training & Development Inputs,46,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Type of Performance Appraisal,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Workforce Breakdown: Gender,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Workforce Breakdown: Other Minorities,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Dimension,Economic Governance Dimension,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Dimension,Environmental Dimension,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Dimension,Social Dimension,69,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Biodiversity,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Climate Strategy,42,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Environmental Policy & Management Systems,44,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Operational Eco-Efficiency,83,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Business Ethics,89,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Corporate Governance,65,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Information Security/ Cybersecurity & System Availability,43,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Innovation Management,37,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Materiality,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Policy Influence,69,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Product Quality & Recall Management,63,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Risk & Crisis Management,47,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Supply Chain Management,49,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Tax Strategy,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Access to Healthcare,68,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Addressing Cost Burden,71,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Corporate Citizenship & Philanthropy,65,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Human Capital Development,58,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Human Rights,29,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Labor Practice Indicators,37,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Marketing Practices,69,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Occupational Health & Safety,74,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Talent Attraction & Retention,73,001602,AMGN,Amgen Inc.
4092820,2022-09-23,S&P Global ESG Score,S&P Global ESG Score,54,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Biodiversity Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate Risk Assessment - Transition Risks,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Climate-Related Scenario Analysis,30,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,EMS: Certification/ Audit/ Verification,51,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Energy Consumption,72,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Environmental Policy & Commitments,37,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Hazardous Waste,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Net-Zero Commitment,8,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,No Deforestation Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Physical Climate Risk Adaptation,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Water Consumption,67,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Average Tenure,98,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Codes of Conduct: Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Compliance to Regulatory Standards,55,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Contributions & Other Spending,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Corruption & Bribery Cases,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Critical Supplier Identification,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,ESG Integration in SCM Strategy,90,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Effective Tax Rate,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,IT Security/ Cybersecurity Governance,25,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,IT Security/ Cybersecurity Measures,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,IT Security/ Cybersecurity Process & Infrastructure,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Material Issues for Enterprise Value Creation,58,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Open Innovation,95,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Process Innovations,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Product Recalls (Health Care),71,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,R&D breakout by Innovation Phase,40,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Reporting on breaches,17,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Risk Governance,10,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supply Chain Risk Exposure,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Supply Chain Transparency & Reporting,36,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,UN Global Compact Membership,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Access to Healthcare Programs (Products & Drugs),40,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Corporate Citizenship Strategy,68,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Discrimination & Harassment,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Employee Development Programs,76,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Employee Support Programs,64,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Employee Turnover Rate,63,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Hiring,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Assessment,34,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Commitment,84,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Impact on Access to Healthcare,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,OHS Policy,66,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,OHS Programs,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,People Analytics,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Philanthropic Contributions,26,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Strategic Workforce Planning,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Type of Performance Appraisal,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Workforce Breakdown: Gender,50,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Workforce Breakdown: Other Minorities,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Dimension,Economic Governance Dimension,55,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Dimension,Environmental Dimension,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Dimension,Social Dimension,52,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Biodiversity,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Climate Strategy,41,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Environmental Policy & Management Systems,44,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Operational Eco-Efficiency,83,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Business Ethics,89,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Corporate Governance,65,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Information Security/ Cybersecurity & System Availability,35,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Innovation Management,29,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Materiality,56,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Policy Influence,69,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Product Quality & Recall Management,63,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Risk & Crisis Management,47,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Supply Chain Management,49,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Tax Strategy,0,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Access to Healthcare,39,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Addressing Cost Burden,47,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Corporate Citizenship & Philanthropy,65,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Human Capital Development,30,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Human Rights,29,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Labor Practice Indicators,31,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Marketing Practices,33,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Occupational Health & Safety,74,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-09-23,Criteria,Talent Attraction & Retention,48,001602,AMGN,Amgen Inc.
4092820,2022-11-18,S&P Global ESG Score,S&P Global ESG Score,62,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Biodiversity Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate Risk Assessment - Transition Risks,25,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate-Related Scenario Analysis,30,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,EMS: Certification/ Audit/ Verification,51,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Energy Consumption,72,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Environmental Policy & Commitments,37,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Hazardous Waste,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Net-Zero Commitment,8,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,No Deforestation Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Physical Climate Risk Adaptation,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Water Consumption,67,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Average Tenure,98,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Codes of Conduct: Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Compliance to Regulatory Standards,55,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Contributions & Other Spending,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Corruption & Bribery Cases,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Critical Supplier Identification,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,ESG Integration in SCM Strategy,90,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Effective Tax Rate,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,IT Security/ Cybersecurity Governance,25,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,IT Security/ Cybersecurity Measures,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,IT Security/ Cybersecurity Process & Infrastructure,23,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Material Issues for Enterprise Value Creation,58,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Open Innovation,95,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Process Innovations,54,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Product Recalls (Health Care),71,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,R&D breakout by Innovation Phase,40,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Reporting on breaches,17,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Risk Governance,10,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supply Chain Risk Exposure,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supply Chain Transparency & Reporting,36,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,UN Global Compact Membership,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Access to Healthcare Programs (Products & Drugs),40,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Corporate Citizenship Strategy,68,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Discrimination & Harassment,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Employee Development Programs,76,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Employee Support Programs,64,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Employee Turnover Rate,63,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Ethical Marketing - Complaints Tracking,89,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Fair Pricing,67,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Gender Pay Indicators,30,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Hiring,42,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Capital Return on Investment,45,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Assessment,34,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Commitment,84,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Impact on Access to Healthcare,71,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Long-Term Incentives for Employees,81,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,OHS Policy,66,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,OHS Programs,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Patent Filing Policy,71,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,People Analytics,89,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Philanthropic Contributions,26,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Strategic Workforce Planning,77,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Training & Development Inputs,46,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Type of Performance Appraisal,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Workforce Breakdown: Gender,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Workforce Breakdown: Other Minorities,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Dimension,Economic Governance Dimension,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Dimension,Environmental Dimension,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Dimension,Social Dimension,69,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Biodiversity,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Climate Strategy,42,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Environmental Policy & Management Systems,44,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Operational Eco-Efficiency,83,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Business Ethics,89,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Corporate Governance,65,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Information Security/ Cybersecurity & System Availability,43,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Innovation Management,37,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Materiality,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Policy Influence,69,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Product Quality & Recall Management,63,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Risk & Crisis Management,47,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Supply Chain Management,49,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Tax Strategy,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Access to Healthcare,68,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Addressing Cost Burden,71,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Corporate Citizenship & Philanthropy,65,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Human Capital Development,58,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Human Rights,29,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Labor Practice Indicators,37,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Marketing Practices,69,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Occupational Health & Safety,74,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Talent Attraction & Retention,73,001602,AMGN,Amgen Inc.
4092820,2022-11-18,S&P Global ESG Score,S&P Global ESG Score,54,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Biodiversity Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate Risk Assessment - Transition Risks,25,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate-Related Management Incentives,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Climate-Related Scenario Analysis,30,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Coverage of Environmental Management Policy,40,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,EMS: Certification/ Audit/ Verification,51,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Emissions Reduction Targets,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Energy Consumption,72,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Environmental Policy & Commitments,37,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Environmental Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Financial Opportunities Arising from Climate Change,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Hazardous Waste,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Net-Zero Commitment,8,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,No Deforestation Commitment,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Physical Climate Risk Adaptation,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Waste Disposal,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Water Consumption,67,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Anti-Competitive Practices,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Average Tenure,98,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Gender Diversity,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Industry Experience,61,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Board Type,85,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Codes of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Codes of Conduct: Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Codes of Conduct: Systems/ Procedures,78,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Compliance to Regulatory Standards,55,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Contributions & Other Spending,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Corruption & Bribery,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Corruption & Bribery Cases,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Critical Supplier Identification,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Dual Class Shares,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,ESG Integration in SCM Strategy,90,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Effective Tax Rate,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Emerging Risks,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,IT Security/ Cybersecurity Governance,25,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,IT Security/ Cybersecurity Measures,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,IT Security/ Cybersecurity Process & Infrastructure,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Material Issues for Enterprise Value Creation,58,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Materiality Analysis,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Open Innovation,95,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Process Innovations,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Product Recalls (Health Care),71,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,R&D breakout by Innovation Phase,40,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Reporting on breaches,17,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Risk Culture,32,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Risk Governance,10,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supplier Code of Conduct,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supplier Risk Management Measures,25,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supply Chain Risk Exposure,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Supply Chain Transparency & Reporting,36,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,UN Global Compact Membership,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Access to Healthcare Programs (Products & Drugs),40,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Accessibility & Transparency of Outcome Data,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Contribution to Increasing Healthcare Efficiency,70,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Corporate Citizenship Strategy,68,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Discrimination & Harassment,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Employee Development Programs,76,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Employee Support Programs,64,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Employee Turnover Rate,63,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,HTA Support of Value Proposition,75,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Hiring,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Assessment,34,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Commitment,84,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Impact on Access to Healthcare,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Local Capacity Building,90,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Measure Contribution to Health Outcome,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,OHS Policy,66,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,OHS Programs,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,People Analytics,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Philanthropic Contributions,26,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Social Reporting - Assurance,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Social Reporting - Coverage,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Strategic Workforce Planning,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Trend of Employee Wellbeing,80,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Type of Performance Appraisal,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Type of Philanthropic Activities,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Workforce Breakdown: Gender,50,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Workforce Breakdown: Other Minorities,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Dimension,Economic Governance Dimension,55,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Dimension,Environmental Dimension,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Dimension,Social Dimension,52,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Biodiversity,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Climate Strategy,42,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Environmental Policy & Management Systems,44,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Environmental Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Operational Eco-Efficiency,83,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Business Ethics,89,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Corporate Governance,65,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Information Security/ Cybersecurity & System Availability,35,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Innovation Management,29,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Materiality,56,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Policy Influence,69,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Product Quality & Recall Management,63,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Risk & Crisis Management,47,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Supply Chain Management,49,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Tax Strategy,0,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Access to Healthcare,39,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Addressing Cost Burden,47,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Corporate Citizenship & Philanthropy,65,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Health Outcome Contribution,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Human Capital Development,30,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Human Rights,29,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Labor Practice Indicators,31,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Marketing Practices,33,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Occupational Health & Safety,74,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Social Reporting,100,001602,AMGN,Amgen Inc.
4092820,2022-11-18,Criteria,Talent Attraction & Retention,48,001602,AMGN,Amgen Inc.
4092820,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,48,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Biodiversity Commitment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Biodiversity Risk Assessment,23,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate Governance,85,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate-Related Scenario Analysis,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Coverage of Environmental Management Policy,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),85,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,EMS: Certification/ Audit/ Verification,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Emissions Reduction Targets,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Energy Consumption,91,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Environmental Policy & Commitments,37,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Exposure to Hazardous Substances,38,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Financial Opportunities Arising from Climate Change,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Hazardous Waste,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),88,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Life Cycle Assessment,28,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Net-Zero Commitment,16,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,No Deforestation Commitment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Physical Climate Risk Adaptation,30,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Product Design Criteria,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Waste Disposal,98,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Water Consumption,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Average Tenure,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Gender Diversity,44,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Independence,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Industry Experience,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Type,88,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Codes of Conduct,75,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,56,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Compliance to Regulatory Standards,37,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Contributions & Other Spending,33,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Emerging Risks,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,IT Security/ Cybersecurity Governance,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,5,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,KPIs for Supplier Assessment and Development,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,KPIs for Supplier Screening,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Material Issues for External Stakeholders,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Materiality Analysis,25,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Materiality Metrics for External Stakeholders,8,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Open Innovation,14,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Process Innovations,52,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Product Recalls (Health Care),83,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,R&D breakout by Innovation Phase,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Reporting on breaches,10,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Risk Culture,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Risk Governance,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Risk Management Processes,10,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier Assessment and Development,15,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier Code of Conduct,83,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier ESG Program,25,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier Screening,65,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Sustainability Reporting Boundaries,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Sustainability Taxonomies,,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,UN Global Compact Membership,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Accessibility & Transparency of Outcome Data,52,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,68,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Discrimination & Harassment,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Employee Development Programs,44,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Employee Support Programs,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Employee Turnover Rate,35,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Ethical Marketing - Complaints Tracking,82,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Fair Pricing,47,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Gender Pay Indicators,31,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,HTA Support of Value Proposition,61,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Hiring,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Assessment,44,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Commitment,84,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Impact on Access to Healthcare,82,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Local Capacity Building,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Long-Term Incentives for Employees,69,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,33,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Measure Contribution to Health Outcome,53,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,OHS Policy,78,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,OHS Programs,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Training & Development Inputs,45,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Trend of Employee Wellbeing,24,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Type of Performance Appraisal,35,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Workforce Breakdown: Gender,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Dimension,Economic Governance Dimension,46,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Dimension,Environmental Dimension,56,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Dimension,Social Dimension,48,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Biodiversity,5,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Climate Strategy,54,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Environmental Policy & Management Systems,36,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Product Stewardship,38,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Business Ethics,57,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Corporate Governance,62,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,52,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Innovation Management,28,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Materiality,35,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Policy Influence,56,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Product Quality & Recall Management,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Risk & Crisis Management,20,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Supply Chain Management,26,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Access to Healthcare,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Addressing Cost Burden,58,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Health Outcome Contribution,53,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Human Capital Development,31,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Human Rights,32,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Labor Practice Indicators,48,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Marketing Practices,66,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Occupational Health & Safety,54,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Talent Attraction & Retention,47,001602,AMGN,Amgen Inc.
4092820,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,36,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Biodiversity Commitment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Biodiversity Risk Assessment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate Governance,85,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate Risk Management,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate-Related Management Incentives,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Climate-Related Scenario Analysis,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Coverage of Environmental Management Policy,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),85,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,EMS: Certification/ Audit/ Verification,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Emissions Reduction Targets,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Energy Consumption,91,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Environmental Policy & Commitments,37,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Exposure to Hazardous Substances,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Financial Opportunities Arising from Climate Change,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Financial Risks of Climate Change,10,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Hazardous Waste,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),88,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Life Cycle Assessment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Net-Zero Commitment,16,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,No Deforestation Commitment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Physical Climate Risk Adaptation,30,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Product Design Criteria,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,TCFD Disclosure,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Waste Disposal,98,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Water Consumption,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Average Tenure,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Diversity Policy,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Effectiveness,68,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Gender Diversity,44,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Independence,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Industry Experience,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Board Type,88,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,46,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,CEO Compensation - Success Metrics,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Codes of Conduct,75,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,56,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Compliance to Regulatory Standards,37,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Contributions & Other Spending,33,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Corruption & Bribery,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Effective Tax Rate,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Emerging Risks,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Family Ownership,,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Government Ownership,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,IT Security/ Cybersecurity Governance,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,5,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,KPIs for Supplier Assessment and Development,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,KPIs for Supplier Screening,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Largest Contributions & Expenditures,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Management Ownership,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Management Ownership Requirements,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Material Issues for Enterprise Value Creation,67,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Material Issues for External Stakeholders,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Materiality Analysis,25,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Materiality Metrics for External Stakeholders,8,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Open Innovation,14,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Process Innovations,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Product Innovations (Healthcare),8,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Product Recalls (Health Care),83,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,R&D Spending,,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,R&D breakout by Innovation Phase,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Reporting on breaches,10,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Risk Culture,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Risk Governance,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Risk Management Processes,10,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier Assessment and Development,15,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier Code of Conduct,83,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier ESG Program,25,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Supplier Screening,65,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Sustainability Reporting Assurance,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Sustainability Reporting Boundaries,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Sustainability Taxonomies,,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Tax Reporting,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Tax Strategy and Governance,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,UN Global Compact Membership,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Accessibility & Transparency of Outcome Data,52,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Direct-to-Consumer Marketing,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Discrimination & Harassment,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Employee Development Programs,44,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Employee Support Programs,70,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Employee Turnover Rate,35,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Ethical Marketing - Complaints Tracking,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Ethical Marketing Commitment,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Fair Pricing,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Fatalities,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Freedom of Association,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Gender Pay Indicators,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,HTA Support of Value Proposition,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Hiring,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Capital Return on Investment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Assessment,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Commitment,84,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Due Diligence Process,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Human Rights Mitigation & Remediation,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Impact on Access to Healthcare,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Local Capacity Building,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Long-Term Incentives for Employees,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Measure Contribution to Health Outcome,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,OHS Policy,78,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,OHS Programs,80,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Patent Filing Policy,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Training & Development Inputs,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Trend of Employee Wellbeing,24,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Type of Performance Appraisal,35,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Workforce Breakdown: Gender,50,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Dimension,Economic Governance Dimension,43,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Dimension,Environmental Dimension,51,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Dimension,Social Dimension,25,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Biodiversity,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Climate Strategy,54,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Environmental Policy & Management Systems,36,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Product Stewardship,12,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Business Ethics,57,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Corporate Governance,62,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,52,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Innovation Management,20,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Materiality,35,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Policy Influence,56,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Product Quality & Recall Management,60,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Risk & Crisis Management,3,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Supply Chain Management,26,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Tax Strategy,21,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Access to Healthcare,24,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Addressing Cost Burden,0,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Health Outcome Contribution,26,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Human Capital Development,15,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Human Rights,21,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Labor Practice Indicators,40,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Marketing Practices,33,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Occupational Health & Safety,49,001602,AMGN,Amgen Inc.
4092820,2023-10-27,Criteria,Talent Attraction & Retention,29,001602,AMGN,Amgen Inc.
